Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

December 12, 2000

Synthroid® Tablets Recalled

Mount Olive, NJ (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Knoll Pharmaceutical Company is recalling certain Synthroid® tablets because of mis-packaging. 100 mcg product was packaged into 200 mcg card.

This is the first public notice of this Class II recall issued by FDA.

a) Synthroid® tablets (Levothyroxine sodium tablets, USP) 112 mcg (0.112mg);
b) Synthroid® tablets (Levothyroxine sodium tablets, USP), 200 mcg (0.2mg).

Recall #D-053/054-1.

a) Lot #00045501, physician samples, 4 cards of 7 tablets;

b) Lot #00045517, physician samples, 4 cards of 7 tablets.
NDC Numbers: 0048-1140 and 0048-1080-96.

Knoll Pharmaceuticals, Jayuya, Puerto Rico.

Knoll Pharmaceutical Company, Mount Olive, New Jersey, by E-mail on November 16, 2000. Firm-initiated recall ongoing.


a) 17,476 (boxes of 4 cards); b) 12,998 (boxes of 4 cards) were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers December 12, 2000.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

SafetyAlerts compiles comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.